Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers.

Privia Health Group, Inc. offers high-growth potential with recurring revenue model and strong relationships. Learn more ...

This article was reviewed by Knox Beasley, MD. Rogaine vs Minoxidil: What’s Best for Hair Growth? Growing up, you may have ...

Alabama State football was in complete control Saturday, Oct. 4, at ASU Stadium in the 52-35 win over Bethune-Cookman, ...

Looking for the best gifts for her? From under-$10 stocking stuffers to splurge-worthy home and kitchen upgrades, our top picks include something for every budget and personality ...

I’m a therapist and I’ve helped Everyday Health test and review over 400 products. These are the sensory-friendly, fun, and thoughtful gifts we give our friends with ADHD, Autism, or OCD.

Hims & Hers Health HIMS-3.85%decrease; red down pointing triangle said it is now providing menopause care, marking the company’s latest push into hormone-replacement therapies. The telehealth company ...

This article was reviewed by Felix Gussone, MD. How Long Does Enclomiphene Stay in Your System? Testosterone plays a major ...

The company is replacing its COO. It disclosed this in a regulatory document. After market close Thursday, Hims & Hers disclosed in a regulatory filing that COO Nader Kabbani had vacated his position.

Shares of Hims & Hers Health climbed after the company said it is now providing menopause and perimenopause treatment plans on its telehealth platform. The stock rose 5.7% to $57.08 on Wednesday.

Femi Aremu, PharmD, is a Drug Information Pharmacist for Red Ventures and practiced in a COVID-19 clinic for the University of Chicago Medicine. Ozempic (semaglutide) is a medicine used to manage ...

Senior Research Fellow in AI Accountability, Queensland University of Technology Aaron J. Snoswell was previously part of a research team that competitively won a grant to receive research project ...